European Society of Cardiology Jun 20 2025 New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint inhibitors.  The study was led by Assistant Professor Pilar Martín, Head of the Regulatory Molecules of Inflammation Lab at the Spanish National Center for Cardiovascular Research (CNIC) and group leader at CIBER-CV, she explained, "Immune checkpoint